WHOOP Launches Advanced Labs in the UAE with Diagnostic Partner Unilabs, Delivering A Comprehensive View of Health For Members WHOOP, the human performance company, today announced a partnership with Unilabs, a leading international provider of medical diagnostic services, to expand…
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early…
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for…
GE HealthCare and CDL Nuclear Technologies Partner to Expand Access to Flyrcado™, a Novel Cardiac PET Imaging Agent, Across the United States GE HealthCare (Nasdaq: GEHC) has announced a pivotal Distribution and Services Agreement (DSA) with CardioNavix, a division of…
PureTech Showcases Differentiated IPF Strategy, Highlights Patient Insights, and Positions Deupirfenidone as a Potential New Standard of Care PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), a clinical-stage biotherapeutics company devoted to transforming outcomes for patients facing devastating diseases, took center…
PureTech Health Launches Celea Therapeutics to Transform the Treatment Landscape for Respiratory Diseases PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company committed to developing groundbreaking therapies for patients with devastating conditions, has announced…
NorthStar Medical Technologies Appoints Jon Coulter as Non-Executive Chairman, Marking a Key Step in Leadership Succession for Continued Growth in the Radiopharmaceutical Sector NorthStar Medical Technologies, LLC, a recognized global innovator in the development, production, and commercialization of advanced radiopharmaceuticals…
Genentech and Roche Unveil Comprehensive Advances in Alzheimer’s Disease Research at AAIC 2025 At the 2025 Alzheimer’s Association International Conference (AAIC), held in Toronto from July 27 to 30, Genentech and Roche took center stage with a sweeping showcase of…
EyeDura Therapeutics Wins Top Industry Honors as Its Sustained-Release Eye Drop Technology Gains Momentum in Ophthalmology Innovation EyeDura Therapeutics Inc., a trailblazing developer of preservative-free, sustained-release ophthalmic therapies, has garnered prominent recognition across two of the ophthalmology industry’s most respected…
Nuclidium Secures $99M Series B to Advance Copper-Based Radiopharma Platform Swiss biotech Nuclidium has raised approximately $99 million in a Series B funding round to accelerate the development of its copper-based radiopharmaceutical platform. The round was led by Kurma Growth…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of partnerships in women’s health, providing unparalleled insights into over 150…
WuXi AppTec’s Nantong Facility Wins 2025 Architizer A+Award for Excellence in Human-Centered Industrial Design WuXi AppTec, a globally recognized provider of research, development, and manufacturing services for the pharmaceutical and life sciences industries, has proudly announced that its Nantong facility…